Recombinant Production and Characterization of SAC, the Core Domain of Par-4, by SUMO Fusion System

Jian Zhang1, Aiyou Sun2, Yuguo Dong1

  • 1State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology, Shanghai, 200237, China.

Insights

Prostate apoptosis response-4 (Par-4) core domain, SAC, effectively inhibits ovarian cancer cell growth and induces apoptosis by binding to GRP78. This study presents an efficient method for producing bioactive SAC for potential cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Prostate apoptosis response-4 (Par-4) is an anticancer protein targeting cancer cell proliferation and apoptosis.
  • The core domain of Par-4 (SAC) demonstrates tumor growth inhibition without harming normal tissues.
  • The therapeutic potential of SAC in ovarian cancer remains unexplored.

Purpose of the Study:

  • To develop an effective method for producing native SAC in prokaryotic cells.
  • To evaluate the anticancer effects of recombinant SAC on ovarian cancer cells.
  • To elucidate the mechanism of SAC-induced apoptosis in ovarian cancer.

Main Methods:

  • A small ubiquitin-related modifier (SUMO) fusion system was employed for recombinant SAC production in E. coli.
  • Ni-NTA affinity chromatography was used for purification, followed by SUMO protease cleavage.
  • Ovarian cancer cell proliferation and apoptosis assays were performed, along with immunofluorescence and binding studies.

Main Results:

  • A simplified, one-step purification process yielded highly pure (95%) recombinant SAC with a yield of 25 mg/L.
  • Recombinant SAC significantly inhibited proliferation and induced apoptosis in SKOV-3 ovarian cancer cells.
  • SAC specifically binds to the cell surface receptor GRP78 to trigger apoptosis in SKOV-3 cells.

Conclusions:

  • An effective strategy for expressing bioactive SAC in prokaryotic systems was established.
  • Recombinant SAC exhibits potent anticancer activity against ovarian cancer cells.
  • The findings support the potential application of SAC in ovarian cancer therapy.

Related Concept Videos

Recombinant DNA Technology01:34

Recombinant DNA Technology

Scientists create recombinant DNA by combining DNA from different sources—often, other species—in the laboratory. DNA cloning allows researchers to study specific genes by inserting them into easily manipulated cells, such as bacteria. Organisms that contain recombinant DNA are known as genetically modified organisms (GMOs). Recombinant DNA technology produces organisms with new genes that can benefit science, medicine, and agriculture.How Do Scientists Create Recombinant DNA?Creation of...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Recombinant DNA01:34

Recombinant DNA

Scientists create recombinant DNA by combining DNA from different sources—often, other species—in the laboratory. DNA cloning allows researchers to study specific genes by inserting them into easily manipulated cells, such as bacteria. Organisms that contain recombinant DNA are known as genetically modified organisms (GMOs). Recombinant DNA technology produces organisms with new genes that can benefit science, medicine, and agriculture.How Do Scientists Create Recombinant DNA?Creation of...
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...